Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT05773274 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 35 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 16, 2026 (5 days ago) |
As of October 21, 2026: Clinical trial NCT05773274 is currently recruiting participants. This phase2 study for neuroendocrine tumors is actively seeking new participants at 35 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05773274 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05773274 was last updated 5 days ago (October 16, 2026). HelloStudys verifies this status automatically.